Related Experiment Video
Updated: Jul 2, 2026

10:52
Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques
Published on: June 1, 2016
Spatial heterogeneity in microglia-complement crosstalk: Implications for synaptic pruning in Alzheimer's disease.
Qiuyan Ye1, Wei Gao2, Jiaping Feng3
1Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|February 5, 2026
Summary
Microglia and complement interactions drive synaptic loss in Alzheimer's disease (AD), showing regional differences. Combining Western and traditional Chinese medicine may offer new treatments for synaptic pruning.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Alzheimer's disease (AD) is characterized by early-stage synaptic loss.
- Microglia-complement interactions are central to synaptic pruning, a key pathological feature in AD.
- These interactions display significant spatial heterogeneity in AD.
Purpose of the Study:
- To review the synergistic mechanisms of microglia and complement in physiological synaptic pruning.
- To analyze the evolution of the complement-immune network in AD progression.
- To explore genetic factors amplifying spatial heterogeneity in synaptic pruning.
Main Methods:
- Systematic literature review.
- Analysis of microglia-complement interactions in synaptic pruning.
- Exploration of genetic influences on synaptic pruning heterogeneity.
Main Results:
- Microglia and complement systems play a synergistic role in synaptic pruning.
- The complement-immune network dynamically evolves during AD progression.
- Genetic factors amplify spatial heterogeneity in synaptic pruning.
Conclusions:
- Understanding microglia-complement interactions is crucial for AD research.
- Targeting synaptic pruning offers therapeutic potential for AD.
- Combined Western and traditional Chinese medicine approaches may be beneficial for AD treatment.
Related Concept Videos
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

